Targeting MRSA penicillin-binding protein 2a: structural insights, allosteric mechanisms, and the potential of adjuvant inhibitors
Top Cited Papers
Open Access
- 6 June 2025
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 239, 117048
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Foundation for Science and Technology (UIDB/00100/2020)
This publication has 122 references indexed in Scilit:
- Designing novel nucleoside inhibitors targeting the allosteric site of PBP2a: A strategic approach to overcome resistance in MRSABioorganic & Medicinal Chemistry, 2025
- Elucidating allosteric signal disruption in PBP2a: impact of N146K/E150K mutations on ceftaroline resistance in methicillin-resistant Staphylococcus aureusJournal of Computer-Aided Molecular Design, 2025
- Synergistic evaluation of Moringa oleifera extract and ß-lactam antibiotic to restore the susceptibility of methicillin-resistant Staphylococcus aureusMolecular Biology Reports, 2021
- Molecular Dynamics Simulations of Antibiotic Ceftaroline at the Allosteric Site of Penicillin‐Binding Protein 2a (PBP2a)Israel Journal of Chemistry, 2020
- Constructing and deconstructing the bacterial cell wallProtein Science, 2019
- Peptidoglycan architecture of Gram-positive bacteria by solid-state NMRBiochimica et Biophysica Acta (BBA) - Biomembranes, 2015
- Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteriaAdvanced Drug Delivery Reviews, 2014
- Penicillin‐binding protein 2a of methicillin‐resistant Staphylococcus aureusIUBMB Life, 2014
- Substrate specificity of bacterial DD-peptidases (penicillin-binding proteins)Cellular and Molecular Life Sciences, 2008
- β-Lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genomeCellular and Molecular Life Sciences, 2005